Advertisement

Topics

AbbVie Receives CHMP Positive Opinion for MAVIRET™ (glecaprevir/pibrentasvir) for the ...

08:47 EDT 23 Jun 2017 | BioMedReports - Blog

The CHMP positive opinion is supported by 97.5 percent (n=807/828) SVR 12rates with 8 weeks of MAVIRET across GT1-6 chronic HCV infected patients without

Read more...

Original Article: AbbVie Receives CHMP Positive Opinion for MAVIRET™ (glecaprevir/pibrentasvir) for the ...

NEXT ARTICLE

More From BioPortfolio on "AbbVie Receives CHMP Positive Opinion for MAVIRET™ (glecaprevir/pibrentasvir) for the ..."

Advertisement
Quick Search
Advertisement
Advertisement